This content is machine translated Osteoporosis Risk-stratified therapy with osteoanabolic agents improves outcomes Patients with a very high or imminent fracture risk should be considered for (first-line) therapy with ostoanabolic substances. Both patient selection and planning of therapy sequences are decisive factors for...…
View Post 6 min This content is machine translated Postmenopausal osteoporosis: long-term therapy concepts Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects Postmenopausal osteoporosis in women is a consequence of decreasing oestrogen levels and is associated with rapid bone loss (“high-turnover osteoporosis”). Long-term therapy concepts are required to achieve sustainable effects –...…
View Post 7 min This content is machine translated CKD-MBD Therapy of osteoporosis in chronic renal insufficiency Renal dysfunction leads to serious changes in bone density and mineralization. These irregularities are grouped under the term CKD-MBD (Chronic Kidney Disease – Mineral and Bone Disorder) . A review…
